logo

For the Inventor, By the Inventor

Foster City, CA, United States of America

De-Chao Yu

USPTO Granted Patents = 14

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 253(Granted Patents)


Location History:

  • Foster City, CA (US) (2000 - 2009)
  • Palo Alto, CA (US) (2011)

Company Filing History:

goldMedal11 out of 78 
 
Cell Genesys, Inc.
 patents
silverMedal2 out of 10 
 
Calydon, Inc.
 patents
bronzeMedal1 out of 2 
 
Cold Genesys, Inc.
 patents

Years Active: 2000-2011

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7968333 - Adenovirus vectors containing cell status-specific response elements and methods of use thereof (2011-06-28),
2. 7575919 - Adenovirus vectors containing cell status-specific response elements and methods of use thereof (2009-08-18),
3. 7364727 - Metastatic colon cancer specific promoter and uses thereof (2008-04-29),
4. 7319033 - Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof (2008-01-15),
5. 7276233 - Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy (2007-10-02),
6. 7074618 - Adenoviral E1A/E1B complementing cell line (2006-07-11),
7. 6991935 - Target cell-specific adenoviral vectors containing E3 and methods of use thereof (2006-01-31),
8. 6911200 - Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation (2005-06-28),
9. 6852528 - Human and mouse uroplakin II gene transcriptional regulatory elements (2005-02-08),
10. 6692736 - Cell-specific adenovirus vectors comprising an internal ribosome entry site (2004-02-17),
11. 6436394 - Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof (2002-08-20),
12. 6432700 - Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same (2002-08-13),
13. 6197293 - Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof (2001-03-06),
14. 6051417 - Prostate cancer drug screening using hKLK2 enhancer (2000-04-18),

Title: De-Chao Yu: A Visionary Innovator in Adenoviral Vector Technology

Introduction

De-Chao Yu, based in Foster City, California, is a prominent inventor known for his contributions to biotechnology. With a portfolio of 14 patents, Yu’s innovative work primarily revolves around adenoviral vectors and their applications in cell-specific therapies.

Latest Patents

Yu's latest patents include groundbreaking inventions such as "Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof." This invention introduces adenoviral vectors that incorporate cell status-specific transcriptional regulatory elements, allowing for targeted transcriptional regulation of adenoviral genes based on reversible physiological and environmental states. Furthermore, it encompasses compositions and host cells featuring these vectors, alongside novel methods for their application in research and treatment.

Career Highlights

Throughout his career, De-Chao Yu has made significant strides in the field of biotechnology. His tenure at companies like Cell Genesys, Inc. and Calydon, Inc. marks a period of substantial contributions to the advancement of genetic engineering and therapeutic methods using viral vectors. His inventive spirit and determination have positioned him as a key figure in developing targeted therapies.

Collaborations

During his career, Yu has collaborated with notable professionals such as Daniel R. Henderson and Eric R. Schuur. These partnerships have fostered a rich exchange of ideas and innovative strategies that have propelled advancements in their respective fields of expertise.

Conclusion

De-Chao Yu stands out as an influential innovator in adenoviral vector technology. His dedication to research and innovation continues to impact the biotechnology landscape, potentially ushering in new possibilities for medical treatments and therapies. His impressive track record of 14 patents serves as a testament to his visionary approach and commitment to excellence in the realm of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…